Fisher & Paykel Healthcare chief executive Lewis Gradon has called the company’s full-year results a “year like no other” when the output of some hospital products was six times higher, propelling record net profits and an increased final dividend.
The dual-listed company is a designer and manufacturer of products used in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnoea (OSA).
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
